aTyr Pharma, Inc. (ATYR) Market Cap & Valuation Ratios
aTyr Pharma, Inc. (ATYR) has a market cap of $16.2M and a price-to-sales ratio of 85.2, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ATYRaTyr Pharma, Inc.Follow ATYR — free
—
Price chart with a free account
- Market cap
- 16.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Peers
biotechnology · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| ATYR | 0.0 | — | — | — | — | -19% | — | -142% |
| NKTX | 0.1 | — | — | — | — | — | — | -50% |
| AVXL | 0.1 | — | — | — | — | — | — | — |
| HUMA | 0.1 | — | 36.5 | — | — | +159% | — | — |
| VYGR | 0.1 | — | — | — | — | -19% | -340% | -74% |
| LENZ | 0.1 | — | 3.5 | — | — | — | — | -75% |
| HRTX | 0.1 | — | 1.0 | — | — | +1.0% | -7% | -8% |
| ALDX | 0.0 | — | — | — | — | — | — | — |
| EYPT | 0.0 | — | — | — | — | -95% | — | -275% |
| IRLA | 0.0 | — | — | — | — | — | — | — |
| SCNI | 0.0 | — | 0.6 | — | — | +30% | — | -102% |
| Median of these 10 | — | 2.3 | — | — | +1.0% | -174% | -74% |
.
Growth vs. price
each dot a company · hover or tap for valuesaTyr Pharma, Inc. — questions
- What is aTyr Pharma, Inc.'s market cap?
- $16.2M.
- What is aTyr Pharma, Inc.'s price-to-sales ratio?
- 85.2.
Every figure on this page comes from aTyr Pharma, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.